D.E. Shaw & Co’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.62M | Buy |
|
|||||
|
2025
Q1 | $6.57M | Sell |
|
|||||
|
2024
Q4 | $5.7M | Sell |
|
|||||
|
2024
Q3 | $8.73M | Buy |
|
|||||
|
2024
Q2 | $13.5M | Buy |
|
|||||
|
2024
Q1 | $7.47M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Buy |
|
|||||
|
2023
Q3 | $253K | Sell |
|
|||||
|
2023
Q2 | $405K | Sell |
|
|||||
|
2023
Q1 | $1.09M | Sell |
|
|||||
|
2022
Q4 | $1.97M | Sell |
|
|||||
|
2022
Q3 | $3.8M | Sell |
|
|||||
|
2022
Q2 | $4.51M | Sell |
|
|||||
|
2022
Q1 | $11.6M | Buy |
|
|||||
|
2021
Q4 | $12.3M | Sell |
|
|||||
|
2021
Q3 | $15.3M | Sell |
|
|||||
|
2021
Q2 | $30.5M | Sell |
|
|||||
|
2021
Q1 | $35.8M | Sell |
|
|||||
|
2020
Q4 | $47.9M | Buy |
|
|||||
|
2020
Q3 | $31M | Sell |
|
|||||
|
2020
Q2 | $31.2M | Sell |
|
|||||
|
2020
Q1 | $27.3M | Sell |
|
|||||
|
2019
Q4 | $66.9M | Buy |
|
|||||
|
2019
Q3 | $30.3M | Buy |
|
|||||
|
2019
Q2 | $25.5M | Sell |
|
|||||
|
2019
Q1 | $36M | Buy |
|
|||||
|
2018
Q4 | $27.3M | Buy |
|
|||||
|
2018
Q3 | $18.4M | Buy |
|
|||||
|
2018
Q2 | $17M | Sell |
|
|||||
|
2018
Q1 | $26.9M | Buy |
|
|||||
|
2017
Q4 | $8.97M | Buy |
|
|||||
|
2017
Q3 | $3.88M | Buy |
|
|||||
|
2017
Q2 | $794K | Buy |
|
|||||
|
2017
Q1 | $439K | Buy |
|
|||||
|
2016
Q4 | $185K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.04M | Buy |
|
|||||
|
2016
Q1 | $943K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.47M | Sell |
|
|||||
|
2015
Q2 | $7.13M | Buy |
|
|||||
|
2015
Q1 | $185K | Sell |
|
|||||
|
2014
Q4 | $197K | Buy |
|